Cefotaxime

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Broad-spectrum cephalosporin 3rd generation.

Half-life
This section has been translated automatically.

1,1–1,6 h

Spectrum of action
This section has been translated automatically.

Bordetella pertussis, Borrelia burgdorferi, Citrobacter spp., Clostridium spp., Enterobacter spp., E. coli, Hafnia alvei, Haemophilus spp., Klebsiella spp., Moraxella spp., Morganella morganii, Neisseria spp, Peptostreptococcus spp., Prevotella spp., Proteus spp., Providencia spp., Salmonella spp., Serratia spp., Shigella spp., Staphylococcus spp., Streptococcus spp., Yersinia spp.

Indication
This section has been translated automatically.

Severe, life-threatening respiratory tract, urinary tract, skin, soft tissue, bone and joint infections. Therapy of acute neuroborreliosis.

Dosage and method of use
This section has been translated automatically.

  • 2 times/day 1-2 g i.v. (max. 3 times/day 2 g or 4 times/day 3 g).
  • Children: 50-100 mg/kg bw/day in 2-4 ED (max. 150-250 mg/kg bw/day).
  • Lyme disease: 2 times/day 3 g for 14-21 days.

Preparations
This section has been translated automatically.

Cefotaxim-ratiopharm, Claforan

Outgoing links (1)

Cephalosporins;

Authors

Last updated on: 29.10.2020